Fourthly, there are some molecular tumor markers, such as KRAS, NRAS, and BRAF, that might have promising relevance between LM and their positive value 39,40, but it was impossible to collect these data in the present study because those biomarkers were not performed in all cases during the study period. The gene discussed is BRAF; the disease is neoplasm.